| Optical Coherence Tomography Applications | Lifetime | 19 | IT 1 | 99.57 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 31 | IT 3 | 99.41 |
| Cutaneous Melanoma Detection and Management | Lifetime | 52 | IT 4 | 99.41 |
| Cell Image Analysis Techniques | Lifetime | 44 | IT 1 | 98.93 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 55 | IT 6 | 99.20 |
| melanin and skin pigmentation | Lifetime | 96 | IT 7 | 98.66 |
| Cancer and Skin Lesions | Lifetime | 129 | IT 8 | 98.65 |
| Skin Protection and Aging | Lifetime | 133 | IT 4 | 98.51 |
| Dermatologic Treatments and Research | Lifetime | 180 | IT 10 | 97.99 |
| Genetic and rare skin diseases. | Lifetime | 96 | IT 8 | 97.64 |
| Dermatology and Skin Diseases | Lifetime | 481 | IT 26 | 97.68 |
| Nail Diseases and Treatments | Lifetime | 426 | IT 21 | 96.67 |
| AI in cancer detection | Lifetime | 614 | IT 18 | 95.52 |
| Infectious Diseases and Mycology | Lifetime | 355 | IT 21 | 95.48 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 622 | IT 65 | 95.49 |
| Melanoma and MAPK Pathways | Lifetime | 530 | IT 23 | 94.86 |
| Advanced Biosensing Techniques and Applications | Lifetime | 740 | IT 19 | 92.22 |
| Acne and Rosacea Treatments and Effects | Lifetime | 812 | IT 28 | 86.60 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 531 | IT 63 | 77.68 |
| Neonatal skin health care | Lifetime | 930 | IT 29 | 47.63 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 1 | IT 1 | 99.68 |
| Optical Coherence Tomography Applications | 2021-2025 | 6 | IT 1 | 99.18 |
| Skin Protection and Aging | 2021-2025 | 6 | IT 1 | 99.12 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 11 | IT 2 | 99.56 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 14 | IT 4 | 98.31 |
| melanin and skin pigmentation | 2021-2025 | 26 | IT 2 | 97.12 |
| Dermatologic Treatments and Research | 2021-2025 | 41 | IT 7 | 97.62 |
| Cancer and Skin Lesions | 2021-2025 | 57 | IT 6 | 94.18 |
| Dermatology and Skin Diseases | 2021-2025 | 227 | IT 32 | 96.66 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 320 | IT 59 | 92.89 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 351 | IT 53 | 89.35 |
| Melanoma and MAPK Pathways | 2021-2025 | 241 | IT 19 | 88.40 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 741 | IT 81 | 88.97 |
| Cell Image Analysis Techniques | 2021-2025 | 565 | IT 22 | 80.48 |
| Infectious Diseases and Mycology | 2021-2025 | 345 | IT 33 | 75.31 |
| Drug-Induced Adverse Reactions | 2021-2025 | 624 | IT 53 | 74.34 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 464 | IT 22 | 71.59 |
| Medicine and Dermatology Studies History | 2021-2025 | 136 | IT 3 | 67.37 |
| Nail Diseases and Treatments | 2021-2025 | 953 | IT 64 | 68.56 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 381 | IT 60 | 68.28 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 468 | IT 41 | 62.29 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 941 | IT 86 | 57.42 |
| Dermatological and COVID-19 studies | 2021-2025 | 702 | IT 139 | 52.65 |
| Genetic and rare skin diseases. | 2021-2025 | 709 | IT 68 | 37.95 |
| Dermatological and Skeletal Disorders | 2021-2025 | 944 | IT 129 | 33.77 |
